✦ LIBER ✦

De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate

✍ Scribed by Joachim Havla; Lisa Ann Gerdes; Ingrid Meinl; Markus Krumbholz; Hans Faber; Frank Weber; Hannah Luise Pellkofer; Reinhard Hohlfeld; Tania Kümpfel

Book ID: 106095295
Publisher: Springer
Year: 2011
Tongue: English
Weight: 217 KB
Volume: 258
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s00415-011-5996-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Spasticity improvement in patients with

Spasticity improvement in patients with relapsing–remitting multiple sclerosis switching from interferon-β to glatiramer acetate: The Escala Study

✍ J.E. Meca-Lallana; J.J. Balseiro; F. Lacruz; C. Guijarro; O. Sanchez; A. Cano; L 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 416 KB

Short-term combination of glatiramer ace

Short-term combination of glatiramer acetate with IV steroid treatment preceding treatment with GA alone assessed by MRI-disease activity in patients with relapsing–remitting multiple sclerosis

✍ Nicola De Stefano; Massimo Filippi; Clive Hawkins 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 175 KB